Biotech ETFs for 2026 Opportunities and Considerations for Investors PM Q1 2026 Earnings EPS Beats Estimates by 414 Amidst Operational Challenges US Government Stake Speculation Intensifies Traders Eye IonQ Micron and Anduril as Next Candidates